2013 | 2012 | ||||||||||||||||||||||
Gross Carrying Amount | Accumulated Amortization | Net | Gross Carrying Amount | Accumulated Amortization | Net | ||||||||||||||||||
Products and product rights | $ | 41,691 | $ | 21,216 | $ | 20,475 | $ | 41,932 | $ | 16,678 | $ | 25,254 | |||||||||||
In-process research and development | 1,856 | — | 1,856 | 2,393 | — | 2,393 | |||||||||||||||||
Tradenames | 1,632 | 310 | 1,322 | 1,521 | 236 | 1,285 | |||||||||||||||||
Other | 958 | 810 | 148 | 896 | 745 | 151 | |||||||||||||||||
$ | 46,137 | $ | 22,336 | $ | 23,801 | $ | 46,742 | $ | 17,659 | $ | 29,083 |
Pharmaceutical | All Other | Total | |||||||||
Goodwill balance January 1, 2012 | $ | 10,107 | $ | 2,048 | $ | 12,155 | |||||
Other (1) | (21 | ) | — | (21 | ) | ||||||
Goodwill balance December 31, 2012 | 10,086 | 2,048 | 12,134 | ||||||||
Acquisitions | 103 | 188 | 291 | ||||||||
Divestitures | (45 | ) | — | (45 | ) | ||||||
Other (1) | (79 | ) | — | (79 | ) | ||||||
Goodwill balance December 31, 2013 | $ | 10,065 | $ | 2,236 | $ | 12,301 |